108 related articles for article (PubMed ID: 9720717)
41. The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.
Kuss BJ; Deeley RG; Cole SP; Willman CL; Kopecky KJ; Wolman SR; Eyre HJ; Callen DF
Leuk Lymphoma; 1996 Feb; 20(5-6):357-64. PubMed ID: 8833390
[TBL] [Abstract][Full Text] [Related]
42. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
Ichikawa H; Tanabe K; Mizushima H; Hayashi Y; Mizutani S; Ishii E; Hongo T; Kikuchi A; Satake M
Br J Haematol; 2006 Nov; 135(3):336-47. PubMed ID: 16989659
[TBL] [Abstract][Full Text] [Related]
43. Spectral karyotyping and fluorescence in situ hybridization analyses identified a novel three-way translocation involving inversion 16 in therapy-related acute myeloid leukemia M4eo.
Ohsaka A; Otsubo K; Yokota H; Hisa T; Saito H; Kozaki T
Cancer Genet Cytogenet; 2008 Jul; 184(2):113-8. PubMed ID: 18617061
[TBL] [Abstract][Full Text] [Related]
44. Cohabiting t(12;22) and inv(3) primary rearrangements in an acute myelomonocytic leukemia (FAB M4) cell line.
MacLeod RA; Hu ZB; Kaufmann M; Drexler HG
Genes Chromosomes Cancer; 1996 Jun; 16(2):144-8. PubMed ID: 8818662
[TBL] [Abstract][Full Text] [Related]
45. Novel CBF beta-MYH11 fusion transcripts and alternative splicing in acute myeloid leukemia with inversion of chromosome 16.
Novak M; Laczika K; Mitterbauer M; Purtscher B; Scheidel-Petrovic A; Lechner K; Jaeger U; Haas OA
Blood; 1995 Sep; 86(6):2449-50. PubMed ID: 7662994
[No Abstract] [Full Text] [Related]
46. Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients.
Monma F; Nishii K; Shiga J; Sugahara H; Lorenzo F; Watanabe Y; Kawakami K; Hosokai N; Yamamori S; Katayama N; Shiku H
Leuk Res; 2007 Apr; 31(4):471-6. PubMed ID: 17052753
[TBL] [Abstract][Full Text] [Related]
47. Clinical aspects of expression of inversion 16 chromosomal fusion transcript CBFB/MYH11 in acute myelogenous leukemia subtype M1 with abnormal bone marrow eosinophilia.
Monahan BP; Rector JT; Liu PP; Cotelingam JD; Dahut W
Leukemia; 1996 Oct; 10(10):1653-4. PubMed ID: 8847901
[TBL] [Abstract][Full Text] [Related]
48. Dual color FISH on CBF primary acute myeloid leukemia.
Sorour A; Nafea D
Egypt J Immunol; 2008; 15(2):25-31. PubMed ID: 20306685
[TBL] [Abstract][Full Text] [Related]
49. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
Dissing M; Le Beau MM; Pedersen-Bjergaard J
J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
[TBL] [Abstract][Full Text] [Related]
50. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
[TBL] [Abstract][Full Text] [Related]
51. Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.
Merchant SH; Haines S; Hall B; Hozier J; Viswanatha DS
J Mol Diagn; 2004 Aug; 6(3):271-4. PubMed ID: 15269306
[TBL] [Abstract][Full Text] [Related]
52. Detection of CBF beta/MYH11 mRNA in bone marrow smears.
Karlic H; Pavlova B; Koller E
Leukemia; 1995 Mar; 9(3):520. PubMed ID: 7885052
[No Abstract] [Full Text] [Related]
53. [Complex additional chromosomal abnormalities of del(5q), del(7q), and +22 in a patient with acute myelomonocytic leukemia carrying inv(16)].
Nakaya A; Fujita H; Tachibana T; Takemura S; Ishigatsubo Y
Rinsho Ketsueki; 2004 Sep; 45(9):1061-3. PubMed ID: 15510837
[TBL] [Abstract][Full Text] [Related]
54. [Acute myelomonocytic leukemia with inv(16) (p13q22) developed in a case of ovarian cancer].
Yaguchi M; Nehashi Y; Torii Y; Ohyashiki K; Toyama K
Rinsho Ketsueki; 1988 Aug; 29(8):1282-6. PubMed ID: 3204678
[No Abstract] [Full Text] [Related]
55. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.
Sorensen PH; Chen CS; Smith FO; Arthur DC; Domer PH; Bernstein ID; Korsmeyer SJ; Hammond GD; Kersey JH
J Clin Invest; 1994 Jan; 93(1):429-37. PubMed ID: 8282816
[TBL] [Abstract][Full Text] [Related]
56. Myelodysplastic syndrome preceding acute myelomonocytic leukemia with dysplastic marrow eosinophilia and inv(16).
Horiike S; Misawa S; Nishida K; Nishigaki H; Tsuda S; Taniwaki M; Takino T; Abe T
Acta Haematol; 1989; 82(3):161-4. PubMed ID: 2510440
[TBL] [Abstract][Full Text] [Related]
57. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
[TBL] [Abstract][Full Text] [Related]
58. "Isolated" peritoneal granulocytic sarcoma with molecular and chromosomal bone marrow involvement.
Billio A; Pianezze G; Amato B; Fabris P
Haematologica; 2002 Jan; 87(1):EIM01. PubMed ID: 11801482
[No Abstract] [Full Text] [Related]
59. The inv(16) in acute nonlymphocytic leukemia: a turnabout for myosin heavy chain.
Willard HF
Hum Mol Genet; 1993 Oct; 2(10):1525-6. PubMed ID: 8268904
[No Abstract] [Full Text] [Related]
60. A novel translocation (1;2)(p34;p21-22) in acute myelomonoblastic leukemia.
Lossos IS; Bogomolski-Yahalome V; Yehuda O; Ben-Neriah S; Ben-Yehuda D; Leizerowitz R; Polliack A
Cancer Genet Cytogenet; 1998 Oct; 106(1):78-9. PubMed ID: 9772915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
